The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.

Nature
Jing HuangMing Lei

Abstract

Menin is a tumour suppressor protein whose loss or inactivation causes multiple endocrine neoplasia 1 (MEN1), a hereditary autosomal dominant tumour syndrome that is characterized by tumorigenesis in multiple endocrine organs. Menin interacts with many proteins and is involved in a variety of cellular processes. Menin binds the JUN family transcription factor JUND and inhibits its transcriptional activity. Several MEN1 missense mutations disrupt the menin-JUND interaction, suggesting a correlation between the tumour-suppressor function of menin and its suppression of JUND-activated transcription. Menin also interacts with mixed lineage leukaemia protein 1 (MLL1), a histone H3 lysine 4 methyltransferase, and functions as an oncogenic cofactor to upregulate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis. A recent report on the tethering of MLL1 to chromatin binding factor lens epithelium-derived growth factor (LEDGF) by menin indicates that menin is a molecular adaptor coordinating the functions of multiple proteins. Despite its importance, how menin interacts with many distinct partners and regulates their functions remains poorly understood. Here we present the crystal structures of human menin in it...Continue Reading

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jul 1, 1995·Trends in Biochemical Sciences·J R LambP Hieter
Apr 18, 1997·Science·S C ChandrasekharappaS J Marx
Jun 8, 2002·The Journal of Biological Chemistry·Oya Yazgan, Curt M Pfarr
Jan 16, 2007·Molecular and Cellular Endocrinology·Yuqing Yang, Xianxin Hua
Oct 25, 2007·Nature Reviews. Cancer·Andrei V Krivtsov, Scott A Armstrong
Jul 5, 2008·Cancer Cell·Akihiko Yokoyama, Michael L Cleary
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Oct 22, 2010·The Journal of Biological Chemistry·Jolanta GrembeckaTomasz Cierpicki
Jul 16, 2011·The Journal of Biological Chemistry·Marcelo J MuraiTomasz Cierpicki
Aug 20, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Edith J Mensah-OsmanJuanita L Merchant

❮ Previous
Next ❯

Citations

Jul 16, 2013·Trends in Biochemical Sciences·Smita MatkarXianxin Hua
Sep 3, 2013·Quarterly Reviews of Biophysics·Zhanxin Wang, Dinshaw J Patel
Apr 13, 2013·Cell Death & Disease·Y-J YangE-J Cho
Nov 29, 2012·European Journal of Human Genetics : EJHG·Urielle UllmannMaryse Bonduelle
Mar 22, 2013·Leukemia·J de BoerO Williams
Jul 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Belete A DesimmieFrauke Christ
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Bin XuGuang-Hui Jin
Mar 20, 2013·Molecular and Cellular Biology·Rick van NulandH T Marc Timmers
May 16, 2012·Journal of Molecular Endocrinology·Gabriele CapursoGianfranco Delle Fave
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Lingyan JinGuowei Fang
Aug 20, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Erica ShenSchahram Akbarian
Mar 19, 2014·Future Medicinal Chemistry·Tomasz Cierpicki, Jolanta Grembecka
Nov 13, 2015·Cancer Biology & Therapy·Xin HeXianxin Hua
Jul 25, 2014·Nucleic Acids Research·Madapura M PradeepaWendy A Bickmore
Aug 29, 2012·Molecular Biology International·Oliver TaltynovZeger Debyser
Sep 27, 2015·Endocrine-related Cancer·Stephen John Marx
Aug 19, 2014·International Journal of Endocrinology·Shadia ZamanStephen J Marx
Jun 3, 2016·Frontiers in Physiology·Sergio A Alcalá-CoronaEnrique Hernández-Lemus
May 22, 2016·Endocrine-related Cancer·Yulong Li, William F Simonds
Jul 1, 2016·Biology Direct·Tamas LazarAgnes Tantos
Aug 5, 2014·Biochemical and Biophysical Research Communications·Tae-Yang SongEun-Jung Cho
Mar 9, 2017·Cell Reports·Koen M A DreijerinkMyles Brown
Jan 15, 2017·The American Journal of Pathology·Laurent EhrlichShannon Glaser
Jan 1, 2012·Cancers·Erica Ballabio, Thomas A Milne
Nov 1, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takeshi YamadaMasakatsu Yamashita
Apr 5, 2018·Journal of Molecular Endocrinology·Sucharitha Iyer, Sunita K Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.